The Life Sciences Report

Experience, Creativity And Dedication To Finding And Presenting The Best Investment Ideas
Contributor's Links: The Life Sciences Report
The Life Sciences Report features leading investment coverage of the life sciences sector, including biotechnology, pharmaceuticals, tools & diagnostics, and medical devices. A Streetwise Reports publication. The Streetwise Reports Team combines experience, creativity and dedication to ...more
Following: 17 Followers: 2715

ALL CONTRIBUTIONS

MRI Device Maker's Earnings Come In At High End Of Forecasts
Wednesday, August 3, 2022 12:19 PM EDT
After its earnings beat, improved margins and disciplined cost control measures, IRadimed keeps its buy rating and its price target has been raised to $42/share (up from $40).
In this article: IRMD
Read
HC Staffing Firm Posts Triple-Digit Revenue Gains In Q421
Saturday, February 19, 2022 8:45 PM EDT
AMN Healthcare Services traded 12% higher after the company reported Q4/21 financial results that included a 116% YoY increase in revenue and a 1,149% YoY increase in net income.
In this article: AMN
Read
Inotiv Makes $545 Million Bid For Envigo RMS Holdings To Fortify Research And Drug Discovery Platforms
Tuesday, September 21, 2021 6:03 PM EDT
Shares of Inotiv Inc. traded 27% higher to a new 52-week high after the company reported it entered into an agreement to acquire Envigo RMS Holding Corp. in a cash and stock deal valued at $545 million.
In this article: NOTV
Read
Oil Breaking Out, But The Money Is Elsewhere
Monday, October 9, 2017 11:07 PM EDT
One resource industry dwarfs the rest of them put together: energy.
Read
Immunotherapy Company's Q2 Revenue 'Handily Beats' H.C. Wainwright's Projection
Thursday, August 17, 2017 1:17 PM EDT
Inovio Pharmaceuticals Inc. exited Q2/17 with $92 million in cash. It has closed a public offering that yielded $70.5 million, which "would be used for general corporate purposes, including clinical trial expenses.
In this article: INO
Read
HIV Vaccine Clinical Study Results In High Immune Response Rates In Healthy Subjects
Wednesday, June 7, 2017 12:01 PM EDT
A clinical study of an HIV vaccine in healthy subjects that found a nearly 100% immune response rate was hailed by a pair of industry analysts. Inovio Pharmaceuticals Inc. has a "buy" rating.
In this article: INO Also: GILD
Read
All Posts

STOCKS I FOLLOW

ABBV AbbVie Inc.
ABT Abbott Laboratories
ACAD ACADIA Pharmaceuticals Inc.
ACFN Acorn Energy Inc.
ACHN Achillion Pharmaceuticals Inc.
ACOR Acorda Therapeutics, Inc.
ACRX AcelRx Pharmaceuticals Inc.
ACTC ADVANCED CELL TECH
ADDXF ADDEX PHARMA ORD
ALPMF ASTELLAS PHARMA INC
AMBS Amarantus Bioscience Holdings Inc
APRI Apricus Biosciences, Inc
ARIA ARIAD Pharmaceuticals Inc.
ARNA Arena Pharmaceuticals, Inc.
Load More

TWEETS

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications

The Life Sciences Report
Streetwise Reports

Focused on biotechnology, pharmaceuticals, medical devices, tools and diagnostics.